Global Compounding Pharmacies Market: Analysis By Product Type (Oral, Topical, Ophthalmic, Injectables, Others), By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology, Others), End User (Adult, Pediatric, Geriatric, Veterinary), By Region, By Country (2019 Edition): Opportunities and Forecast (2014-2024) - By Region (North America, Europe, APAC, ROW), By Country (US, Canada, UK, Germany, China, Japan, India, Brazil, Mexico)

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies and stakeholders) and secondary research, the report aims to present the analysis of Global Compounding Pharmacies Market. The report has further analysed the Compounding Pharmacies Market by By Product Type (Oral, Topical, Ophthalmic, Injectables and Others), By Therapeutic Area (Hormone Replacement, Pain Management, Dermatology and Others) and By End User (Adult, Pediatric, Geriatric and Veterinary). The Global Compounding Pharmacies Market has been analysed By Region (North America, Europe, Asia Pacific, ROW) and By Country (United States, Canada, United Kingdom, Germany, China, Japan, India, Brazil and Mexico) for the historical period of 2014-2018 and the forecast period of 2019-2024.

Valued at approximately USD 9689.56 million in the year 2018, the global compounding pharmacies market is being influenced by several key factors such as rising share of elderly individuals, increase in per capita expenditure on healthcare as well as rising trend of adopting personalized medicines. Furthermore, increasing population growth rate with significant share of people suffering from a slew of diseases such as cancers, cardiovascular disorders, hormonal imbalances, etc., have been propelling the demand for customized pharmaceutical products that can be most effective to their individual health conditions. Furthermore, the one-size-fits-all characteristic of majority of mass produced drugs means that several patients requirements are not met. In such circumstances, the patients often rely on the services provided by the compounding pharmacies. Above and beyond, patients utilizing personalized compounded medications often experience fewer side effects than those treated with generic medications. Within the different therapeutic areas of compounded pharmaceutical products, hormone replacement therapy and pain management remained the chief money-spinning segments. On the basis of end user, the global compounding pharmacies market is dominated by adults encompassing the age group of 19 to 64 years.

The report titled has covered and analysed the potential of global compounding pharmacies market and provides statistics and information on market size, shares, market attractiveness and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation.

Scope of the Report

Global Compounding Pharmacies Market (Actual Period: 2014-2018, Forecast Period: 2019-2024)
Global Market - Sizing, Growth, Forecast
Analysis by Product Type - Oral, Topical, Ophthalmic, Injectables, Others
Analysis by Therapeutic Area - Hormone Replacement, Pain Management, Dermatology, Others
Analysis by End User - Adult, Pediatric, Geriatric, Veterinary
Market Attractiveness of Compounding Pharmacies Market By Product, Therapeutic Area, By End-User

Regional Compounding Pharmacies Market- North America, Europe, Asia Pacific, ROW (Actual Period: 2014-2018, Forecast Period: 2019-2024)
Regional Market - Sizing, Growth, Forecast
Analysis by Product Type - Oral, Topical, Ophthalmic, Injectables, Others
Analysis by Therapeutic Area - Hormone Replacement, Pain Management, Dermatology, Others
Analysis by End User - Adult, Pediatric, Geriatric, Veterinary
Regional Market Attractiveness of Compounding Pharmacies Market By Country

Country Analysis - United States, Canada, United Kingdom, Germany, India China, Japan, Brazil, Mexico (Actual Period: 2014-2018, Forecast Period: 2019-2024)
Compounding Pharmacies Market - Sizing, Growth, Forecast

Other Report Highlights:

Market Dynamics - Drivers and Restraints
Market Trends
Competitive Landscape, Company Share Analysis, Merger and Acquisitions of Key Industry Players
SWOT Analysis
Porter Five Force Analysis
Policy and Regulatory Landscape
Company Analysis - Fagron, PharMEDium, Doughertys Pharmacy, ITC Compounding Pharmacy, Fresenius Kabi, Clinigen Group, Absolute Pharmacy, McGuff Compounding Pharmacy Services, Inc., and Harrow Health, Inc.

Customization of the Report
The report could be customized according to the clients specific research requirements. No additional cost will be required to pay for limited additional research.

1. Research Methodology

2. Executive Summary

3. Strategic Recommendations

4. Compounding Pharmacies Market Outlook

5. Global Compounding Pharmacies Market: Growth and Forecast
5.1 By Value (2014-2018)
5.2 By Value (2019-2024)

6. Global Compounding Pharmacies Market: Segment Analysis
6.1 Global Compounding Pharmacies Market, By Product Type:
6.1.1 Global Compounding Pharmacies Market Size, By Product Type, By Value - 2018 (In %)
6.1.2 Global Compounding Pharmacies Market Size, By Product Type, By Value - 2024 (In %)
6.1.3 Global Compounding Pharmacies Market, By Oral Preparations, By Value (2014-2018)
6.1.4 Global Compounding Pharmacies Market, By Oral Preparations, By Value (2019-2024)
6.1.5 Global Compounding Pharmacies Market, By Topical Preparations, By Value (2014-2018)
6.1.6 Global Compounding Pharmacies Market, By Topical Preparations, By Value (2019-2024)
6.1.7 Global Compounding Pharmacies Market, By Ophthalmic Preparations, By Value (2014-2018)
6.1.8 Global Compounding Pharmacies Market, By Ophthalmic Preparations, By Value (2019-2024)
6.1.9 Global Compounding Pharmacies Market, By Injectable Preparations, By Value (2014-2018)
6.1.10 Global Compounding Pharmacies Market, By Injectable Preparations, By Value (2019-2024)
6.1.11 Global Compounding Pharmacies Market, By Other Preparations, By Value (2014-2018)
6.1.12 Global Compounding Pharmacies Market, By Other Preparations, By Value (2019-2024)
6.1.13 Market Opportunity of Global Compounding Pharmacies Market - By Product Type

6.2 Global Compounding Pharmacies Market: Analysis By Therapeutic Area
6.2.1 Global Compounding Pharmacies Market Size, By Therapeutic Area, By Value - 2018 (In %)
6.2.2 Global Compounding Pharmacies Market Size, By Therapeutic Area, By Value - 2024 (In %)
6.2.3 Global Compounding Pharmacies Market, By Hormone Replacement Application, By Value (2014-2018)
6.2.4 Global Compounding Pharmacies Market, By Hormone Replacement Application, By Value (2019-2024)
6.2.5 Global Compounding Pharmacies Market, By Pain Management Application, By Value (2014-2018)
6.2.6 Global Compounding Pharmacies Market, By Pain Management Application, By Value (2019-2024)
6.2.7 Global Compounding Pharmacies Market, By Dermatology Application, By Value (2014-2018)
6.2.8 Global Compounding Pharmacies Market, By Dermatology Application, By Value (2019-2024)
6.2.9 Global Compounding Pharmacies Market, By Other Therapeutic Areas, By Value (2014-2018)
6.2.10 Global Compounding Pharmacies Market, By Other Therapeutic Areas, By Value (2019-2024)
6.2.10 Market Opportunity of Global Compounding Pharmacies Market - By Therapeutic Area

6.3 Global Compounding Pharmacies Market: Analysis By End User
6.3.1 Global Compounding Pharmacies Market Size, By End User, By Value - 2018 (In %)
6.3.2 Global Compounding Pharmacies Market Size, By End User, By Value - 2024 (In %)
6.3.3 Global Compounding Pharmacies Market, By Adult End User, By Value (2014-2018)
6.3.4 Global Compounding Pharmacies Market, By Adult End User, By Value (2019-2024)
6.3.5 Global Compounding Pharmacies Market, By Pediatric End User, By Value (2014-2018)
6.3.6 Global Compounding Pharmacies Market, By Pediatric End User, By Value (2019-2024)
6.3.7 Global Compounding Pharmacies Market, By Geriatric End User, By Value (2014-2018)
6.3.8 Global Compounding Pharmacies Market, By Geriatric End User, By Value (2019-2024)
6.3.9 Global Compounding Pharmacies Market, By Veterinary End User, By Value (2014-2018)
6.3.10 Global Compounding Pharmacies Market, By Veterinary End User, By Value (2019-2024)
6.3.11 Market Opportunity of Global Compounding Pharmacies Market - By End User

7. Global Compounding Pharmacies Market: Regional Analysis
7.1 Global Compounding Pharmacies Market Size, By Region: Breakdown (%)
7.1.1 Global Compounding Pharmacies Market Size, By Region, 2018 (%)
7.1.2 Global Compounding Pharmacies Market Size, By Region, 2024F (%)
7.2 North America Compounding Pharmacies Market: Growth and Forecast
7.2.1 By Value (2014-2018)
7.2.2 By Value (2019-2024)
7.2.3 North America Compounding Pharmacies Market- Company Share Analysis
7.2.4 By Product Type, By Value (2014-2018)
7.2.5 By Product Type, By Value (2019-2024)
7.2.6 By Therapeutic Area, By Value (2014-2018)
7.2.7 By Therapeutic Area, By Value (2019-2024)
7.2.8 By End User, By Value (2014-2018)
7.2.9 By End User, By Value (2019-2024)

7.3 North America Compounding Pharmacies Market: Country Analysis (U.S and Canada)
7.3.1 Market Attractiveness Chart of North America Compounding Pharmacies Market – By Country, By Value
7.3.2 North America Compounding Pharmacies Market Size, By Country, 2018 (%)
7.3.3 North America Compounding Pharmacies Market Size, By Country, 2024F (%)
7.3.4 U.S Compounding Pharmacies Market, By Value (2014-2018)
7.3.5 U.S Compounding Pharmacies Market, By Value (2019-2024)
7.3.6 Canada Compounding Pharmacies Market, By Value (2014-2018)
7.3.7 Canada Compounding Pharmacies Market, By Value (2019-2024)

7.4 Europe Compounding Pharmacies Market: Growth and Forecast
7.4.1 By Value (2014-2018)
7.4.2 By Value (2019-2024)
7.4.3 Europe Compounding Pharmacies Market- Company Share Analysis
7.4.4 By Product Type, By Value (2014-2018)
7.4.5 By Product Type, By Value (2019-2024)
7.4.6 By Therapeutic Area, By Value (2014-2018)
7.4.7 By Therapeutic Area, By Value (2019-2024)
7.4.8 By End User, By Value (2014-2018)
7.4.9 By End User, By Value (2019-2024)

7.5 Europe Compounding Pharmacies Market: Country Analysis (Germany and U.K)
7.5.1 Market Attractiveness Chart of Europe Compounding Pharmacies Market – By Country, By Value
7.5.2 Europe Compounding Pharmacies Market Size, By Country, 2018 (%)
7.5.3 Europe Compounding Pharmacies Market Size, By Country, 2024F (%)
7.5.4 Germany Compounding Pharmacies Market, By Value (2014-2018)
7.5.5 Germany Compounding Pharmacies Market, By Value (2019-2024)
7.5.6 U.K Compounding Pharmacies Market, By Value (2014-2018)
7.5.7 U.K Compounding Pharmacies Market, By Value (2019-2024)

7.6 APAC Compounding Pharmacies Market: Growth and Forecast
7.6.1 By Value (2014-2018)
7.6.2 By Value (2019-2024)
7.6.3 APAC Compounding Pharmacies Market- Competitive Landscape
7.6.4 By Product Type, By Value (2014-2018)
7.6.5 By Product Type, By Value (2019-2024)
7.6.6 By Therapeutic Area, By Value (2014-2018)
7.6.7 By Therapeutic Area, By Value (2019-2024)
7.6.8 By End User, By Value (2014-2018)
7.6.9 By End User, By Value (2019-2024)

7.6 APAC Compounding Pharmacies Market: Country Analysis (India, China and Japan)
7.6.1 Market Attractiveness Chart of APAC Compounding Pharmacies Market – By Country, By Value
7.6.2 APAC Compounding Pharmacies Market Size, By Country, 2018 (%)
7.6.3 APAC Compounding Pharmacies Market Size, By Country, 2024F (%)
7.6.4 India Compounding Pharmacies Market, By Value (2014-2018)
7.6.5 India Compounding Pharmacies Market, By Value (2019-2024)
7.6.6 China Compounding Pharmacies Market, By Value (2014-2018)
7.6.5 China Compounding Pharmacies Market, By Value (2019-2024)
7.6.6 Japan Compounding Pharmacies Market, By Value (2014-2018)
7.6.7 Japan Compounding Pharmacies Market, By Value (2019-2024)

7.7 ROW Compounding Pharmacies Market: Growth and Forecast
7.7.1 By Value (2014-2018)
7.7.2 By Value (2019-2024)
7.7.3 ROW Compounding Pharmacies Market- Company Share Analysis
7.7.4 By Product Type, By Value (2014-2018)
7.7.5 By Product Type, By Value (2019-2024)
7.7.6 By Therapeutic Area, By Value (2014-2018)
7.7.7 By Therapeutic Area, By Value (2019-2024)
7.7.8 By End User, By Value (2014-2018)
7.7.9 By End User, By Value (2019-2024)

7.8 ROW Compounding Pharmacies Market: Country Analysis (Brazil and Mexico)
7.8.1 Market Attractiveness Chart of APAC Compounding Pharmacies Market – By Country, By Value
7.8.2 ROW Compounding Pharmacies Market Size, By Country, 2018 (%)
7.8.3 ROW Compounding Pharmacies Market Size, By Country, 2024F (%)
7.8.4 Brazil Compounding Pharmacies Market, By Value (2014-2018)
7.8.5 Brazil Compounding Pharmacies Market, By Value (2019-2024)
7.8.6 Mexico Compounding Pharmacies Market, By Value (2014-2018)
7.8.7 Mexico Compounding Pharmacies Market, By Value (2019-2024)

8. Global Compounding Pharmacies Market Dynamics
8.1 Global Compounding Pharmacies Market Drivers
8.2 Global Compounding Pharmacies Market Restraints

9. Global Compounding Pharmacies Market Trends

10. Global Compounding Pharmacies Market
10.1 Competitive Landscape
10.2 Company Share Analysis
10.3 Merger and Acquisitions of Key Industry Players

11. Porter Five Force Analysis

12. SWOT Analysis

13. Policy and Regulatory Landscape

14. Company Profiles
14.1 Fagron
14.2 PharMEDium
14.3 Doughtery’s Pharmacy
14.4 ITC Compounding Pharmacy
14.5 Fresenius Kabi
14.6 Clinigen Group
14.7 Absolute Pharmacy
14.8 McGuff Compounding Pharmacies Services, Inc.
14.9 Pentec Health
14.10 Harrow Health, Inc.

List Of Figures

List of Figures

Figure 1: Global Vascular Stent Market Size, By Value, 2014-2018 (USD Million)
Figure 2: Global Vascular Stent Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 3: Number of people with diabetes, Worldwide, (In million), 2017 & 2045E
Figure 4: Key Facts & Figures About Diabetes
Figure 5: Projected increase in cases of diabetes in 2045, By region (In Percentage)
Figure 6: Top 10 countries for number of adults with diabetes (20-79 years), 2017, (In Million)
Figure 7: Cigarette Sales Share, By Region, 2018 (% of total)
Figure 8: Prevalence of cardiovascular diseases worldwide, In million
Figure 9: GDP Per Capita PPP, By Region, 2018 (in Thousand USD)
Figure 10: Projected global population aged 60 years & above (In Millions)
Figure 11: Global Vascular Stent Market Size, By Type, 2018 (%)
Figure 12: Global Vascular Stent Market Size, By Type, 2024F (%)
Figure 13: Global Vascular Stent Market Size, By Type, 2018 (In %)
Figure 14: Global Vascular Stent Market Size, By Type, 2024 (In %)
Figure 15: Global Coronary Vascular Stent Market, By Value, 2014-2018 (USD Million)
Figure 16: Global Coronary Vascular Stent Market, By Value, Forecast, 2019-2024(USD Million)
Figure 17: Global Peripheral Vascular Stent Market, By Value, 2014-2018 (USD Million)
Figure 18: Global Peripheral Vascular Stent Market, By Value, Forecast, 2019-2024(USD Million)
Figure 19: Market Opportunity Chart of global Vascular Stent Market - By Type, By Value (Year - 2024)
Figure 20: Global Vascular Stent Market Size, By Technology, 2018 (%)
Figure 21: Global Vascular Stent Market Size, By Technology, 2024F (%)
Figure 22: Global Vascular Stent Market Size, By Technology, 2018 (In %)
Figure 23: Global Vascular Stent Market Size, By Technology, 2024 (In %)
Figure 24: Global Bare metal Market, By Value, 2014-2018 (USD Million)
Figure 25: Global Bare metal Market, By Value, Forecast, 2019-2024 (USD Million)
Figure 26: Global Drug eluting Market, By Value, 2014-2018 (USD Million)
Figure 27: Global Drug eluting Market, By Value, Forecast, 2019-2024(USD Million)
Figure 28: Global Bioresorbable Market, By Value, 2014-2018 (USD Million)
Figure 29: Global Bioresorbable Market, By Value, Forecast, 2019-2024(USD Million)
Figure 30: Market Opportunity Chart of global Vascular Stent Market - By Technology, By Value (Year - 2024)
Figure 31: Global Vascular Stent Market Size, By Mode of Delivery, 2018 (%)
Figure 32: Global Vascular Stent Market Size, By Mode of Delivery, 2024F (%)
Figure 33: Global Vascular Stent Market Size, By Mode of delivery, 2018 (In %)
Figure 34: Global Vascular Stent Market Size, By Mode of delivery, 2024 (In %)
Figure 35: Global Self expandable Market, By Value, 2014-2018 (USD Million)
Figure 36: Global Self expandable Market, By Value, Forecast, 2019-2024(USD Million)
Figure 37: Global Balloon expandable Market, By Value, 2014-2018 (USD Million)
Figure 38: Global Balloon expandable Market, By Value, Forecast, 2019-2024(USD Million)
Figure 39: Market Opportunity Chart of global Vascular Stent Market - By Mode of Delivery, By Value (Year - 2024)
Figure 40: Global Vascular Stent Market Size, By End User, 2018 (%)
Figure 41: Global Vascular Stent Market Size, By End User, 2024F (%)
Figure 42: Global Vascular Stent Market Size, By End User, 2018 (In %)
Figure 43: Global Vascular Stent Market Size, By End User, 2024 (In %)
Figure 44: Global Hospital Market, By Value, 2014-2018 (USD Million)
Figure 45: Global Hospital Market, By Value, Forecast, 2019-2024(USD Million)
Figure 46: Global Ambulatory Surgical Centre Market, By Value, 2014-2018 (USD Million)
Figure 47: Global Ambulatory Surgical Centre Market, By Value, Forecast, 2019-2024(USD Million)
Figure 48: Market Opportunity Chart of global Vascular Stent Market - By End User, By Value (Year - 2024)
Figure 49: Global Healthcare Landscape, By Select Region
Figure 50: Global Vascular Stent Market Size, By Region, 2018 (%)
Figure 51: Global Vascular Stent Market Size, By Region, 2024 (%)
Figure 52: North America Vascular Stent Market Size, By Value, 2014-2018 (USD Million)
Figure 53: North America Vascular Stent Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 54: North America population aged 65 and above, 2013-2018 (% of total)
Figure 55: Prevalence of Diabetes in North America, 2017 & 2045E (In Million)
Figure 56: Prevalence of Obesity in United States Among Populace Aged Above 20, 2013-2017 (% of total)
Figure 57: Prevalence of cardiovascular disease in North America, In million
Figure 58: North America GDP, 2012-2017 (USD Trillion)
Figure 59: North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 60: Competitive Positions of Select Companies Operating in North America Vascular Stent Market (2018)
Figure 61: North America Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 62: North America Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 63: North America Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 64: North America Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 65: North America Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 66: North America Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 67: North America Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 68: North America Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 69: North America Vascular Stent Market Size, By Country, 2018 (%)
Figure 70: North America Vascular Stent Market Size, By Country, 2024F (%)
Figure 71: Market Opportunity Chart of North America Vascular Stent Market - By Type, By Value (Year - 2024)
Figure 72: USA Vascular Stent Market, By Value, 2014-2018 (USD Million)
Figure 73: USA Vascular Stent Market, By Value, 2019-2024(USD Million)
Figure 74: Prevalence of cardiovascular diseases in United States, In million
Figure 75: Prevalence of cardiovascular diseases in United States, In million
Figure 76: U.S.A ., Population ages 65 and above, 2013-2017 (% of total)
Figure 77: U.S.A ., Population ages 65 and above, Forecast (In Millions)
Figure 78: U.S.A Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 79: U.S.A Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 80: U.S.A Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 81: U.S.A Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 82: U.S.A Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 83: U.S.A Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 84: U.S.A Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 85: U.S.A Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 86: Canada Vascular Stent Market, By Value, 2014-2018 (USD Million)
Figure 87: Canada Vascular Stent Market, By Value, 2019-2024(USD Million)
Figure 88: Prevalence of cardiovascular diseases in Canada (In %)
Figure 89: Prevalence of Diabetics in Canada, (% of Total Population) 2015 & 2045E
Figure 90: Estimated Prevalence of Pre-Diabetics in Canada, (% of Total Population) 2015 & 2045E
Figure 91: Overweight and Obese Population in Canada, 2015-2017 (% of total)
Figure 92: Canada, Expenditure on Health as a share of GDP, 2012-2017 (In %)
Figure 93: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
Figure 94: Canada, Population ages 65 and above, 2012-2018 (% of total)
Figure 95: Canada Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 96: Canada Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 97: Canada Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 98: Canada Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 99: Canada Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 100: Canada Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 101: Canada Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 102: Canada Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 103: Europe Vascular Stent Market Size, By Value, 2014-2018 (USD Million)
Figure 104: Europe Vascular Stent Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 105: Prevalence of Diabetes (Age 18+), 2017 & 2045E (In Million)
Figure 106: Diabetes Prevalence (% of population ages 20 to 79), By Select Country, 2017
Figure 107: Prevalence of Diabetes Among Children, 2017
Figure 108: Obesity Rate, By Select Country, 2017 (In Percentage)
Figure 109: European Union, Population ages 65 and above, 2013-2018 (% of total)
Figure 110: Per Capita Health Expenditure, By Select Country, 2018 (USD)
Figure 111: European Country Population Aged 65 and Above, 2012-2017 (% of Total)
Figure 112: GDP, Europe Region, By Select Country, 2017 (In Trillion USD)
Figure 113: Competitive Positions of Select Companies Operating in Europe Vascular Stent Market (2018)
Figure 114: Europe Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 115: Europe Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 116: Europe Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 117: Europe Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 118: Europe Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 119: Europe Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 120: Europe Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 121: Europe Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 122: Europe Vascular Stent Market Size, By Country, 2018 (%)
Figure 123: Europe Vascular Stent Market Size, By Country, 2024F (%)
Figure 124: Market Opportunity Chart of Europe Vascular Stent Market - By Type, By Value (Year - 2024)
Figure 125: U.K. Vascular Stent Market, By Value, 2014-2018 (USD Million)
Figure 126: U.K. Vascular Stent Market, By Value, 2019-2024(USD Million)
Figure 127: U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 128: Prevalence of cardiovascular diseases in United Kingdom, In million
Figure 129: U.K, Population Ages 65 and Above (% of total), 2012-2018
Figure 130: U.K. Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 131: U.K. Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 132: U.K. Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 133: U.K. Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 134: U.K. Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 135: U.K. Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 136: U.K. Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 137: U.K. Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 138: Germany Vascular Stent Market, By Value, 2014-2018 (USD Million)
Figure 139: Germany Vascular Stent Market, By Value, 2019-2024(USD Million)
Figure 140: Prevalence of cardiovascular diseases in Germany, (In %)
Figure 141: Germany, Age Structure Breakdown, 2018 (In %)
Figure 142: Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)
Figure 143: Germany, Population ages 65 and above, 2012-2018 (% total)
Figure 144: Germany Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 145: Germany Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 146: Germany Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 147: Germany Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 148: Germany Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 149: Germany Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 150: Germany Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 151: Germany Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 152: France Vascular Stent Market, By Value, 2014-2018 (USD Million)
Figure 153: France Vascular Stent Market, By Value, 2019-2024(USD Million)
Figure 154: Prevalence of cardiovascular disease in France, In thousands
Figure 155: Prevalence of aortic aneurysm in France, In thousands
Figure 156: France, Population Ages 65 and Above (% of total), 2012-2018
Figure 157: France, Spending on Healthcare, 2015 & 2040, (USD Per Person)
Figure 158: France Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 159: France Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 160: France Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 161: France Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 162: France Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 163: France Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 164: France Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 165: France Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 166: Italy Vascular Stent Market, By Value, 2014-2018 (USD Million)
Figure 167: Italy Vascular Stent Market, By Value, 2019-2024(USD Million)
Figure 168: Prevalence of aortic aneurysm in Italy, In Thousands
Figure 169: Prevalence of cardiovascular diseases in Italy, In Thousands
Figure 170: Italy, Health Expenditure, (% of GDP), 2013-2017 (USD)
Figure 171: Italy, Population Ages 65 and Above (% of total), 2012-2018
Figure 172: Italy, Healthcare Infrastructure Related Statistics
Figure 173: Italy, Spending on Healthcare, 2015 & 2040, (USD Per Person)
Figure 174: Italy Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 175: Italy Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 176: Italy Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 177: Italy Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 178: Italy Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 179: Italy Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 180: Italy Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 181: Italy Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 182: APAC Vascular Stent Market Size, By Value, 2014-2018 (USD Million)
Figure 183: APAC Vascular Stent Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 184: APAC, GDP, By Select Country, 2017 (In USD Trillion)
Figure 185: Prevalence of cardiovascular diseases in APAC region, In million
Figure 186: Population ages 65 and above, APAC Region, By Select Countries, 2018 (% of total)
Figure 187: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
Figure 188: Diabetes Prevalence (% of population ages 20 to 79), By Select Country, 2018
Figure 189: Obesity Rate, By Select Country, 2017 (In Percentage)
Figure 190: Competitive Positions of Select Companies Operating in Asia Pacific Vascular Stent Market (2018)
Figure 191: APAC Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 192: APAC Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 193: APAC Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 194: APAC Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 195: APAC Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 196: APAC Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 197: APAC Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 198: APAC Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 199: APAC Vascular Stent Market Size, By Country, 2018 (%)
Figure 200: APAC Vascular Stent Market Size, By Country, 2024F (%)
Figure 201: Market Opportunity Chart of APAC Vascular Stent Market - By Type, By Value (Year - 2024)
Figure 202: India Vascular Stent Market, By Value, 2014-2018 (USD Million)
Figure 203: India Vascular Stent Market, By Value, 2019-2024 (USD Million)
Figure 204: Prevalence of cardiovascular disease in India, In million
Figure 205: India, Population ages 65 and above, 2013-2018, In Million
Figure 206: India, Share of Urban Population, 2012-2018 (In %)
Figure 207: India, GDP Growth Per Year, 2015-2019 (In %)
Figure 208: India, Total Population, 2013-2023F (In Million)
Figure 209: India Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 210: India Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 211: India Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 212: India Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 213: India Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 214: India Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 215: India Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 216: India Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 217: Japan Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 218: Japan Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 219: Japan Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 220: Japan Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 221: Japan Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 222: Japan Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 223: Japan Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 224: Japan Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 225: Japan Vascular Stent Market, By Value, 2014-2018 (USD Million)
Figure 226: Japan Vascular Stent Market, By Value, 2019-2024 (USD Million)
Figure 227: Japan Healthcare Expenditure Outlook (2017) (%)
Figure 228: Medical expenditure in Japan for inpatient and outpatient treatment
Figure 229: Prevalence of diabetes in Japan, In million
Figure 230: Prevalence of cardiovascular disease in Japan, In million
Figure 231: Japan, GDP Growth Per Year, 2015-2019F (In %)
Figure 232: Japan, Population ages 65 and above, 2012-2017 (% of total)
Figure 233: Japan Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 234: Japan Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 235: Japan Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 236: Japan Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 237: Japan Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 238: Japan Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 239: Japan Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 240: Japan Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 241: China Vascular Stent Market, By Value, 2014-2018 (USD Million)
Figure 242: China Vascular Stent Market, By Value, 2019-2024(USD Million)
Figure 243: China, Population ages 65 and above, 2012-2018 (% of total)
Figure 244: China Healthcare Expenditure Outlook (2018) (%)
Figure 245: Prevalence of cardiovascular disease in China, In million
Figure 246: Prevalence of diabetes in China, In million
Figure 247: China, GDP Growth Per Year, 2015-2019 (In %)
Figure 248: China, Share of Urban Population, 2012-2018 (In %)
Figure 249: China, Total Population, 2013-2021F (In Million)
Figure 250: China Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 251: China Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 252: China Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 253: China Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 254: China Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 255: China Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 256: China Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 257: China Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 258: ROW Vascular Stent Market Size, By Value, 2014-2018 (USD Million)
Figure 259: ROW Vascular Stent Market Size, By Value, Forecast, 2019-2024 (USD Million)
Figure 260: Population ages 65 and above, By Select Country, 2017 (% of total)
Figure 261: Population ages 60 or above, By Select Country, 2050 (% of total)
Figure 262: Latin America and Caribbean, Population ages 65 and above 2012-2018 (% of total)
Figure 263: Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2018
Figure 264: Middle East and North Africa, Population ages 65 and above (% of total)
Figure 265: Middle East and North Africa, GDP, 2012-2018 (In USD Trillion)
Figure 266: Prevalence of diabetes in Latin America ad Caribbean, In million
Figure 267: Prevalence of diabetes in Middle East and North Africa, In million
Figure 268: Competitive Positions of Select Companies Operating in ROW Vascular Stent Market (2018)
Figure 269: ROW Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 270: ROW Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 271: ROW Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 272: ROW Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 273: ROW Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 274: ROW Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 275: ROW Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 276: ROW Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 277: ROW Vascular Stent Market Size, By Country, 2018 (%)
Figure 278: ROW Vascular Stent Market Size, By Country, 2024F (%)
Figure 279: Brazil Vascular Stent Market, By Value, 2014-2018 (USD Million)
Figure 280: Brazil Vascular Stent Market, By Value, 2019-2024(USD Million)
Figure 281: Prevalence of diabetes in Brazil, In million
Figure 282: Brazil, Population ages 65 and above, 2012-18 (% of total)
Figure 283: Brazil, GDP, 2012-2018 (In USD Trillion)
Figure 284: Prevalence of cardiovascular disease in Brazil, In Million
Figure 285: Brazil health expenditure as a share of GDP, 2018
Figure 286: Brazil Vascular Stent Market: By Type, By Value, 2014-2018 (USD Million)
Figure 287: Brazil Vascular Stent Market: By Type, By Value, 2019-2024 (USD Million)
Figure 288: Brazil Vascular Stent Market: By Technology, By Value, 2014-2018 (USD Million)
Figure 289: Brazil Vascular Stent Market: By Technology, By Value, 2019-2024 (USD Million)
Figure 290: Brazil Vascular Stent Market: By Mode of Delivery, By Value, 2014-2018 (USD Million)
Figure 291: Brazil Vascular Stent Market: By Mode of Delivery, By Value, 2019-2024 (USD Million)
Figure 292: Brazil Vascular Stent Market: By End User, By Value, 2014-2018 (USD Million)
Figure 293: Brazil Vascular Stent Market: By End User, By Value, 2019-2024 (USD Million)
Figure 294: Global Coronary Stent Market Share, By Select Company, 2018 (In %)
Figure 295: Global Peripheral Stent Market Share, By Select Company, 2018 (In %)
Figure 296: Competitive Positions of Select Companies Operating in the Global Vascular Stent Market (2018)
Figure 297: Classes of Medical Devices
Figure 298: Abbott Laboratories, Sales Revenue, 2014-2018 (USD Million)
Figure 299: Abbott Laboratories, Sales, By Cardiovascular Business Segment, FY ended March 2018 (%)
Figure 300: Abbott Laboratories, Sales, By Geographic Region, FY ended March 2018 (%)
Figure 301: B. Braun Melsungen, Net Sales, 2014-2018 (In Million USD)
Figure 302: Braun Melsungen, Sales, By Business Segment, FY ended March 2018 (%)
Figure 303: B. Braun Melsungen, Net Sales, By Geographic Region, 2018 (In %)
Figure 304: Boston Scientific Corporation, Sales Revenue, 2014-2018 (USD Million)
Figure 305: Boston Scientific Corporation, Sales, By Business Segment, FY ended March 2018 (%)
Figure 306: Boston Scientific Corporation, By Region, FY ended March 2018 (%)
Figure 307: Cardinal Health, Sales Revenue, 2016-2018 (USD Million)
Figure 308: Cardinal Health, Sales, By Business Segment, FY ended March 2018 (%)
Figure 309: Medtronic’s Annual Sales Revenue of Cardiac and Vascular Group,2014-2018 (USD Million)
Figure 310: Medtronic, Sales, By Cardiovascular Business Segment, FY ended March 2018 (%)
Figure 311: Medtronic, By Region, FY ended March 2018 (%)
Figure 312: Terumo Corporation Cardiac and Vascular Group Annual Sales Revenue,2014-2017 (USD Million)
Figure 313: Terumo Corporation, Sales, By Business Segment, FY ended March 2018 (%)
Figure 314: Terumo Corporation, By Region, FY ended March 2018 (%)

List of Tables

Table A: Most common surgeries performed in ambulatory settings, In United States, In 2017
Table B: Facts about cardiovascular diseases in United States, In 2018
Table C: Patient complexity cases in inpatient and outpatient center, By Average Resource Intensity Weight
Table D: Facts about cardiovascular diseases in Canada
Table E: Financial incentives in European Health Systems
Table F: Worldwide tobacco consumption, In 2018
Table G: Facts about cardiovascular diseases across United Kingdom
Table H: Top 5 countries with number of diabetic people across Europe, In million, In 2017
Table I: Germany, Healthcare Related Statistics, 2017
Table J: Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)
Table K: Commonly used drug eluting stents in India
Table L: Commonly used bare metal stents in India
Table M: Prevailing risk factors for cardiovascular diseases across China, In 2018
Table N: Prevailing risk factors for cardiovascular diseases across Brazil, In 2018
Table O: Healthcare spending pattern in Brazil (In USD)
Table P: Average pricing of coronary stents
Table Q: Average pricing of peripheral stents
Table R: Recent FDA approved Vascular Stents
Table S: Major global patent applicants in stents
Table T: Recent Company Acquisitions and Mergers in Compounding Pharmacies Market

Fill The Form For Sample Request

There is no Reviews available